AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22987676 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adults
Number of subjects: 0
Study 22987676 — intervention group
Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0
Study 19846031 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (45 mg and 90 mg)
Number of subjects: 0
Study 19846031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19846031 — intervention group
Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 0
Study 19846031 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0
Study 17536648 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-meter timed walk (10TW)
Number of subjects: 43
Study 17536648 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-meter timed walk (30TW)
Number of subjects: 43
Study 17536648 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG) test
Number of subjects: 43
Study 17536648 — intervention group
Group type: EXPERIMENTAL
Intervention: All tests combined
Number of subjects: 43
Study 14750091 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with benazepril 5 mg and losartan 25 mg
Number of subjects: 24
Study 14750091 — intervention group
Group type: COMPARATOR
Intervention: Losartan (greater dose)
Number of subjects: 24
Study 14750091 — intervention group
Group type: COMPARATOR
Intervention: Benazepril (greater dose)
Number of subjects: 24
Study 11581447 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo), 400 U/kg 3 times weekly
Number of subjects: 290
Study 11581447 — intervention group
Group type: COMPARATOR
Intervention: Placebo/control
Number of subjects: 290
Study 9557587 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive wrist flexion at various angles (10 degrees, 28 degrees, 45 degrees) and forces (5 N, 25 N, 50 N)
Number of subjects: 10
Study 9557587 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous biomechanical measures processed through a force and frequency-weighted filter
Number of subjects: 10
Study 8312419 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cuff Swan neck catheter
Number of subjects: 40
Study 8312419 — intervention group
Group type: COMPARATOR
Intervention: Single-cuff Tenckhoff catheter
Number of subjects: 40
Study 8312419 — intervention group
Group type: EXPERIMENTAL
Intervention: Both catheters
Number of subjects: 40
Study 3072355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 43
Study 3072355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 43
Study 3072355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sexual desire prevalence
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual arousal
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational attainment
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-gynaecological cancer
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic inflammatory disease
Number of subjects: 25446
Study 31945308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic pain
Number of subjects: 25446
Study 29973259 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and Behavioural Change Communication (SBCC) interventions for HIV and TB stigma reduction activities at three social-ecology levels (individual, community, and socio-structural)
Number of subjects: 8
Study 29973259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 8
Study 28107772 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent Reinforcement (CR)
Number of subjects: 30
Study 28107772 — intervention group
Group type: COMPARATOR
Intervention: Non-Contingent Reinforcement (NR)
Number of subjects: 30
Study 28107772 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report (both groups)
Number of subjects: 30
Study 26324176 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 22
Study 26324176 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 22
Study 26324176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 22
Study 26324176 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 22
Study 26324176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 23910197 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically cured adhesive
Number of subjects: 220
Study 23910197 — intervention group
Group type: COMPARATOR
Intervention: Light-cured adhesive
Number of subjects: 220
Study 23910197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 220
Study 22029243 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice sessions (6 minutes, once a month)
Number of subjects: 0
Study 22029243 — intervention group
Group type: COMPARATOR
Intervention: Control group (no practice beyond initial training)
Number of subjects: 0
Study 17356555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk drink containing LGG, La-5 and Bb-12, n=46
Number of subjects: 87
Study 17356555 — intervention group
Group type: COMPARATOR
Intervention: Placebo with heat-killed bacteria, n=41
Number of subjects: 87
Study 16585662 — intervention group
Group type: EXPERIMENTAL
Intervention: Established intervention
Number of subjects: 810
Study 16585662 — intervention group
Group type: EXPERIMENTAL
Intervention: Established plus DASH intervention
Number of subjects: 810
Study 16585662 — intervention group
Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 810
Study 12879279 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylacetate (PAA) administered as a 30-min i.v. infusion at a dose of 1.8 g/m2
Number of subjects: 27
Study 12879279 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylacetate (PAA) administered as a 30-min i.v. infusion at a dose of 2.5 g/m2
Number of subjects: 27
Study 11393682 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate-lowering calcium antagonists (verapamil or diltiazem)
Number of subjects: 1325
Study 9713177 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force application of 50 cN for 4 weeks
Number of subjects: 12
Study 9713177 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force application of 100 cN for 4 weeks
Number of subjects: 12
Study 9713177 — intervention group
Group type: COMPARATOR
Intervention: Non‐moved control teeth
Number of subjects: 12
Study 7999485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 33.2 micrograms
Number of subjects: 14
Study 7999485 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 654 micrograms
Number of subjects: 14
Study 3294122 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin or spiramycin
Number of subjects: 26
Study 3294122 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidiarrhoeal agents (long acting morphine sulphate)
Number of subjects: 26
Study 3294122 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 26
Study 31335356 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 65
Study 27144498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy combined with conventional gel
Number of subjects: 22
Study 27144498 — intervention group
Group type: COMPARATOR
Intervention: Conventional gel only (Control)
Number of subjects: 22
Study 25891453 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) combination group
Number of subjects: 128
Study 25891453 — intervention group
Group type: COMPARATOR
Intervention: Western medicine control group
Number of subjects: 128
Study 23370584 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage (PD)
Number of subjects: 47
Study 23370584 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 47
Study 23370584 — intervention group
Group type: COMPARATOR
Intervention: Control group (Con)
Number of subjects: 47
Study 22411386 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper and pencil FFQ
Number of subjects: 50
Study 22411386 — intervention group
Group type: COMPARATOR
Intervention: Online FFQ
Number of subjects: 50
Study 22411386 — intervention group
Group type: EXPERIMENTAL
Intervention: Both presentations
Number of subjects: 50
Study 19335912 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramucosal pH (pHi) >or= 7.32
Number of subjects: 130
Study 19335912 — intervention group
Group type: COMPARATOR
Intervention: Cardiac index (CI) >or= 3.0 L/min/m2
Number of subjects: 130
Study 16688978 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal letter from consultant summarising consultation
Number of subjects: 150
Study 16688978 — intervention group
Group type: COMPARATOR
Intervention: Brief note thanking for attending clinic
Number of subjects: 150
Study 15488400 — intervention group
Group type: EXPERIMENTAL
Intervention: High-demand subtraction task
Number of subjects: 0
Study 15488400 — intervention group
Group type: COMPARATOR
Intervention: Low-demand subtraction task
Number of subjects: 0
Study 15488400 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-demand subtraction task with novel distractors
Number of subjects: 0
Study 15488400 — intervention group
Group type: COMPARATOR
Intervention: High-demand subtraction task with novel distractors
Number of subjects: 0
Study 11775649 — intervention group
Group type: EXPERIMENTAL
Intervention: Essaven gel (EG)
Number of subjects: 15
Study 11775649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9279488 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dynamic technique (leg extension)
Number of subjects: 120
Study 9279488 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive dynamic technique (knee oscillation)
Number of subjects: 120
Study 9279488 — intervention group
Group type: EXPERIMENTAL
Intervention: Static techniques (massage and isometric quadriceps contractions)
Number of subjects: 120
Study 9279488 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 8290660 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0
Study 8290660 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 8290660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30717951 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent grafts
Number of subjects: 269
Study 30717951 — intervention group
Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 269
Study 27465622 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent stressful life events (SLEs)
Number of subjects: 351
Study 27465622 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress-related symptoms (SRSs)
Number of subjects: 351
Study 27465622 — intervention group
Group type: EXPERIMENTAL
Intervention: Total HRQoL
Number of subjects: 351
Study 27465622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean values of HRQoL
Number of subjects: 351
Study 26333655 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T (hs-cTnT) measurement
Number of subjects: 1074
Study 26333655 — intervention group
Group type: COMPARATOR
Intervention: Serelaxin treatment
Number of subjects: 1074
Study 25489512 — intervention group
Group type: EXPERIMENTAL
Intervention: Spreader graft
Number of subjects: 50
Study 25489512 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlapping lateral crural technique
Number of subjects: 50
Study 25489512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study 20938444 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg Kg(‐1) infusion for 1 hour)
Number of subjects: 30
Study 18708300 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone PR/naloxone PR
Number of subjects: 463
Study 18708300 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone PR
Number of subjects: 463
Study 16621667 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Slouched' posture for 300 seconds
Number of subjects: 32
Study 16621667 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Slouched' posture for 5 minutes
Number of subjects: 32
Study 12794203 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site syphilis testing conducted by primary care nurses
Number of subjects: 7134
Study 12794203 — intervention group
Group type: COMPARATOR
Intervention: Laboratory testing alone
Number of subjects: 7134
Study 12794203 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site syphilis testing
Number of subjects: 7134
Study 11082353 — intervention group
Group type: EXPERIMENTAL
Intervention: ATS mechanical aortic valve
Number of subjects: 300
Study 11082353 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomedics mechanical aortic valve
Number of subjects: 300
Study 11082353 — intervention group
Group type: EXPERIMENTAL
Intervention: St Jude Medical Hemodynamic Plus mechanical aortic valve
Number of subjects: 300
Study 8922355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (avoidance of cow's milk proteins)
Number of subjects: 20
Study 1735849 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal) 5 ml/kg
Number of subjects: 215
Study 6239561 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 6239561 — intervention group
Group type: COMPARATOR
Intervention: Alcuronium
Number of subjects: 0
Study 30887760 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited-excision
Number of subjects: 100
Study 30887760 — intervention group
Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 100
Study 30534816 — intervention group
Group type: EXPERIMENTAL
Intervention: En bloc bipolar ablation
Number of subjects: 90
Study 30534816 — intervention group
Group type: COMPARATOR
Intervention: Conventional TURBT
Number of subjects: 90
Study 27091562 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-reported break-time foods
Number of subjects: 407
Study 27091562 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-reported sugar-sweetened beverages (SSB) consumption
Number of subjects: 407
Study 27091562 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported and child-reported water and fruit consumption
Number of subjects: 407
Study 25198235 — intervention group
Group type: EXPERIMENTAL
Intervention: Deadlift training (twice per week)
Number of subjects: 54
Study 22267245 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium bicarbonate (166 mEq/L) 3 mL/kg for 1 h before and 1 mL/kg/h for 6 h after the procedure (Group B)
Number of subjects: 258
Study 22267245 — intervention group
Group type: COMPARATOR
Intervention: sodium chloride 0.9% 1 mL/kg/h for at least 12h prior and after the procedure (Group A)
Number of subjects: 258
Study 22267245 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium bicarbonate (166 mEq/L) 3 mL/kg over 20 min before the procedure plus sodium bicarbonate orally (500 mg per 10 kg) (Group C)
Number of subjects: 258
Study 20716988 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory feedback signal (Sensor group)
Number of subjects: 16
Study 20716988 — intervention group
Group type: COMPARATOR
Intervention: External device used to restrain the trunk (Stabilizer group)
Number of subjects: 16
Study 17192294 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I administered sc in doses between 60 and 120 microg/kg twice daily
Number of subjects: 76
Study 17192294 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I
Number of subjects: 76
Study 14712431 — intervention group
Group type: COMPARATOR
Intervention: 4 hours dialysis 3 times weekly
Number of subjects: 21
Study 14712431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 hours dialysis 3 times weekly
Number of subjects: 21
Study 14712431 — intervention group
Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 21
Study 14712431 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise predialysis
Number of subjects: 21
Study 14712431 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise during dialysis
Number of subjects: 21
Study 12352419 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 120
Study 12352419 — intervention group
Group type: COMPARATOR
Intervention: Open prostatectomy
Number of subjects: 120
Study 9887898 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 27
Study 9887898 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (Western medicine)
Number of subjects: 27
Study 9887898 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian
Number of subjects: 27
Study 7986302 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin once daily for 6 weeks
Number of subjects: 66
Study 7986302 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin twice daily for 6 weeks
Number of subjects: 66
Study 7986302 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin (both dosages)
Number of subjects: 66
Study 7986302 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 66
Study 7986302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 2554766 — intervention group
Group type: EXPERIMENTAL
Intervention: LY171883 (600 mg) twice daily for 6 weeks
Number of subjects: 138
Study 2554766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 31005345 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Hand Hygiene Monitoring System (EHHMS)
Number of subjects: 91
Study 31005345 — intervention group
Group type: COMPARATOR
Intervention: Human observation (pre-implementation)
Number of subjects: 91
Study 31005345 — intervention group
Group type: COMPARATOR
Intervention: Human observation (post-implementation)
Number of subjects: 91
Study 28371685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity cathodal direct current (CDC)
Number of subjects: 30
Study 28371685 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study 25358059 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSEA)
Number of subjects: 65
Study 25358059 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 65
Study 23635604 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (25 mg) administered 1 day before and 3 days posttransplantation
Number of subjects: 20
Study 23635604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21902995 — intervention group
Group type: EXPERIMENTAL
Intervention: NuSmile(®) crown
Number of subjects: 18
Study 21902995 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinder™Krown
Number of subjects: 18
Study 21902995 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental satisfaction
Number of subjects: 18
Study 21902995 — intervention group
Group type: COMPARATOR
Intervention: Crown wear
Number of subjects: 18
Study 19837425 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvinyl chloride catheter
Number of subjects: 195
Study 19837425 — intervention group
Group type: COMPARATOR
Intervention: Polyvinyl chloride-free catheter
Number of subjects: 195
Study 19837425 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study 16393591 — intervention group
Group type: EXPERIMENTAL
Intervention: L.M.X.4 cream (4% liposomal lidocaine)
Number of subjects: 40
Study 16393591 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream (2.5% lidocaine and 2.5% prilocaine)
Number of subjects: 40
Study 14552846 — intervention group
Group type: EXPERIMENTAL
Intervention: IDEATel intervention, a home-based telemedicine system
Number of subjects: 25
Study 10768435 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg of anti-digoxin Fab
Number of subjects: 66
Study 10768435 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 66
Study 8829177 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.07 +/- 0.003 g/dl)
Number of subjects: 12
Study 1425887 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin (60 mg per day)
Number of subjects: 18
Study 1425887 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (dose adjusted for optimal plasma concentration of 400-600 nmol.l-1)
Number of subjects: 18
Study 1425887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2865152 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, Metoprolol, Pindolol (lipophilic beta-blockers)
Number of subjects: 10
Study 2865152 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (hydrophilic beta-blocker)
Number of subjects: 10
Study 2865152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29909584 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive percutaneous fixation (Group B)
Number of subjects: 60
Study 29909584 — intervention group
Group type: COMPARATOR
Intervention: Traditional open fixation (Group A)
Number of subjects: 60
Study 28967376 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Early Mobilisation (VEM)
Number of subjects: 2104
Study 28967376 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2104
Study 25682859 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine consultation + individualized risk assessment communication intervention
Number of subjects: 102
Study 25682859 — intervention group
Group type: COMPARATOR
Intervention: Routine consultation
Number of subjects: 102
Study 23422370 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 15
Study 23422370 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 15
Study 21935377 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% SPL7013 Gel (VivaGel)
Number of subjects: 11
Study 19752076 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal dimenhydrinate
Number of subjects: 243
Study 19752076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 17179265 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (2 mg/kg IV for 5 min, followed by 3 mg x kg(‐1) x h(‐1) for 10 min)
Number of subjects: 30